The abstract is read at the publisher; the summary is JClub's.
Dengue nanosensors have not succeeded in clinical application, and the key issue is an emphasis on record sensitivity rather than real-world robustness.
- Why it matters: The field lacks a translational pathway that turns highly sensitive lab prototypes into diagnostics that can withstand real-world conditions and perform reliably in patients.
- What they did: The authors propose a product-engineering paradigm shift, moving from materials discovery toward clinical viability planning to guide development from bench to bedside.
- The result: This roadmap is intended to improve the likelihood that dengue nanosensors become viable diagnostics by prioritizing robustness alongside sensitivity during translation.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.